FeesSafety
Pluang+

Law firm investigates Rafael Holdings over possible securities fraud after failed drug trial news.

Market News
11 Nov 2026, 00:29 WIB
GlobeNewsWire
View Source
Bearish
Law firm investigates Rafael Holdings over possible securities fraud after failed drug trial news.

Pomerantz LLP is investigating Rafael Holdings, Inc. for potential securities fraud following the company's announcement that its Phase 3 drug trial for Niemann-Pick Disease Type C did not meet the primary endpoint, causing a nearly 35% drop in its stock price. The investigation focuses on whether Rafael and its executives engaged in unlawful business practices related to this disclosure. Investors affected by the stock decline are encouraged to contact the law firm for possible class action participation. This case highlights risks in biotech investments tied to clinical trial outcomes.

The investigation into Rafael Holdings, Inc. comes amid a challenging environment for health-sector stocks. For readers following this sector, here is Pluang's market snapshot as of Nov 11, 2026 04:52 WIB: out of 150 priced US health stocks, 49 rose and 100 fell. Notable movers include RXRX at USD 3.56 with a 6.44% decline and 100% buy order activity, MRNA at USD 251.81 down 6.39% with a 55% buy order activity, and NVAX at USD 10.20 down 6.34% with 100% sell order activity. Typical hold times range from 23 to 60 days among these stocks.

More News

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures completes control change with Scopien Technologies, rebrands and plans SEC listing.

Cannabis Strategic Ventures has finalized its change of control with Scopien Technologies, an AI platform company, which now holds voting control through preferred stock. The company has appointed new leadership, including CEO Zameer Mulla, and plans...

Company Fundamentals
Bullish
1 hour ago
Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk releases 2025 ESG report highlighting sustainability progress and future goals

Star Bulk Carriers Corp. has published its 2025 Environmental, Social and Governance (ESG) Report, its eighth annual report detailing the company's sustainability strategy, performance, and future objectives. The report, guided by the ESG Committee, ...

Others
Bullish
1 hour ago
TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio cuts operating loss 21% in Q3 2026, boosts international sales and extends cash runway to 2028

TELA Bio reported $19 million revenue in Q3 2026, down 8% year-over-year but with an 18% increase in international sales. The company reduced its operating loss by 21% sequentially and improved adjusted EBITDA loss by 55%, driven by a strategic cost ...

Company Fundamentals
Bullish
1 hour ago
Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation declares $0.27 quarterly dividend payable December 28, 2026.

Auburn National Bancorporation, Inc. announced a quarterly cash dividend of $0.27 per share, payable on December 28, 2026, to shareholders recorded by December 10, 2026. The company is the parent of AuburnBank, an Alabama state-chartered bank with ab...

Company Fundamentals
Neutral
3 hours ago
Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

Québécois plan to dine out more in 2027, seeking value and local favorites, says OpenTable report.

OpenTable's 2027 Quebec dining trends report shows a 9% increase in restaurant bookings, with 65% of Quebecers planning to dine out as much or more in 2027. Consumers prioritize value, local favorites, and meaningful experiences, often celebrating sm...

Market News
Bullish
3 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App